Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with BCAX: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
BCAX
Bicara Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
BCAX
Bicara Therapeutics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
LLY
with
BCAX
Uncorrelated: r 0.22 · 500D.
No shared co-movers.
LLY, solid
BCAX, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
LLY
ELI Lilly & Co
Change
1,426.11
▲
+1.19%
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
BCAX
Bicara Therapeutics Inc.
Change
8.75
▼
−2.36%
Regular session
Nov 4 '26
Mkt cap
$538.7M
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 4 '26
LLY
ELI Lilly & Co
vs
BCAX
Bicara Therapeutics Inc.
1,426.11
▲
+1.19%
Price
8.75
▼
−2.36%
$1.3T
Mkt cap
$538.7M
Q3 FY26
$24.4B
Revenue
—
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,426.11
▲
+1.19%
vs
BCAX
8.75
▼
−2.36%
Regular session
Nov 4 '26